Post
Strategies and innovations for reducing drug product loss in sterile filling
Sterile filling is a critical step in pharmaceutical primary packaging; the transfer of sterile drug product into its final primary …
Seagen reports positive data on Tukysa from Phase III breast cancer trial
Seagen has reported positive topline data from the Phase III HER2CLIMB-02 clinical trial investigating Tukysa (tucatinib) in combination with the …
Geron completes 50% subject enrolment in Phase III myelofibrosis trial
Geron has completed 50% subject enrolment in the Phase III IMpactMF clinical trial of its telomerase inhibitor, imetelstat, to treat …
Syros reports initial findings from acute myeloid leukaemia trial
Syros Pharmaceuticals has reported encouraging initial findings from its SELECT-AML-1 Phase II clinical trial of tamibarotene plus venetoclax and azacitidine …
Q&A: Dr Christina Yap talks about SPIRIT and CONSORT guidance
The CONSORT2010 guidance is used globally when academics are writing papers on clinical trials, providing a checklist for researchers to …
Insilico’s AI-discovered ulcerative colitis drug starts Phase I trial
Hong Kong-based Insilico Medicine has launched a Phase I trial of its artificial intelligence (AI)-discovered drug ISM5411. The Phase I trial …
Strategies and innovations for reducing drug product loss in sterile filling
Sterile filling is a critical step in pharmaceutical primary packaging; the transfer of sterile drug product into its final primary …
Seagen reports positive data on Tukysa from Phase III breast cancer trial
Seagen has reported positive topline data from the Phase III HER2CLIMB-02 clinical trial investigating Tukysa (tucatinib) in combination with the …
Geron completes 50% subject enrolment in Phase III myelofibrosis trial
Geron has completed 50% subject enrolment in the Phase III IMpactMF clinical trial of its telomerase inhibitor, imetelstat, to treat …
Syros reports initial findings from acute myeloid leukaemia trial
Syros Pharmaceuticals has reported encouraging initial findings from its SELECT-AML-1 Phase II clinical trial of tamibarotene plus venetoclax and azacitidine …
Q&A: Dr Christina Yap talks about SPIRIT and CONSORT guidance
The CONSORT2010 guidance is used globally when academics are writing papers on clinical trials, providing a checklist for researchers to …
Delpor on track with schizophrenia implant late-stage trials
Delpor is sketching out late-stage clinical trial plans for its drug-device combination implant DLP-114 (risperidone) in schizophrenia. After presenting topline results …
Anixa and Cleveland Clinic report Phase I breast cancer vaccine data
Anixa Biosciences and Cleveland Clinic in the US have reported positive data from the Phase I clinical trial of breast …
MyMD to begin Phase II trial of rheumatoid arthritis therapy
MyMD Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) application …
Signal: FDA renews Syapse collaboration to use real-world data in oncology
The US Food and Drug Administration (FDA) has renewed a four-year collaboration agreement between its Oncology Center of Excellence and …